Results per Page:
A coordinated care approach rapidly gets COVID-19 therapy into the hands of high-risk cancer patients
From Drs. Eduardo Sanchez, Steven Pergam, and Catherine Liu, ,Fred Hutch Vaccine and Infectious Diseases Division and Cancer Consortium Hematologic Program
Something new and something old synergize to limit multiple myeloma relapse
From the Hill Lab, Translational Science and Therapeutics Division
Two rare antibodies, one drug, four viruses
Researchers discover antibodies to block RSV, other viruses that put transplant patients at risk
Highlights of Fred Hutch science in 2021
From COVID-19 to cancer, Hutch scientists pursued new ideas to save lives
Ongoing trials test COVID-19 drugs for earlier, easier treatment
Injected monoclonal antibodies or oral antivirals could help more patients recover faster
New concerns about coronavirus evolution in immunosuppressed patients
Experts call for tighter precautions, better treatments, more research
Addressing a 'massive unmet need' in COVID-19 treatment
COVID-19 Clinical Research Center tests drugs to reduce severe infections
Hutch researchers discover neutralizing antibodies to parainfluenza
New hope for transplant patients vulnerable to this common respiratory virus
Natural protection from COVID-19 gets boost from a single dose of vaccine
Tests of patients' blood show vaccine stirs antibodies against variants and 2003 SARS virus
Predicting SARS-CoV-2 antibody titers
From the Vaccine and Infectious Disease Division and the University of Washington
Scientists map structure of potent antibody against coronavirus
Computer-generated images show why immune protein neutralizes SARS-CoV-2
Engineering vaccine-like protection without a vaccine
CRISPR gene-editing used on antibody-making B cells
First human antibody found to block Epstein-Barr virus
Early research could open new path for vaccine against EBV-related cancers, mononucleosis
New antibody and unique binding site offer possible paths to malaria prevention
Led by NIH, Fred Hutch researchers, early study holds promise for direct infusion or vaccine design
Good News: $475K gift fuels expansion of antibody tech; Hansen honored for BMT work; Senate passes 21st Century Cures Act
Celebrating faculty and staff achievements
From building toys to developing cures
At 80, transplant scientist Dr. Rainer Storb can't stop tinkering with — and solving — medical puzzles